Alterations in metabolic pathways and networks in Alzheimer's disease

The pathogenic mechanisms of Alzheimer's disease (AD) remain largely unknown and clinical trials have not demonstrated significant benefit. Biochemical characterization of AD and its prodromal phase may provide new diagnostic and therapeutic insights. We used targeted metabolomics platform to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaddurah-Daouk, R, Zhu, H, Sharma, S, Bogdanov, M, Rozen, S G, Matson, W, Oki, N O, Motsinger-Reif, A A, Churchill, E, Lei, Z, Appleby, D, Kling, M A, Trojanowski, J Q, Doraiswamy, P M, Arnold, S E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641405/
https://www.ncbi.nlm.nih.gov/pubmed/23571809
http://dx.doi.org/10.1038/tp.2013.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641405/
https://www.ncbi.nlm.nih.gov/pubmed/23571809
http://dx.doi.org/10.1038/tp.2013.18

Ejemplares similares